MACRO Consulting Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.16M Buy
10,133
+475
+5% +$100K 1.11% 34
2021
Q1
$1.97M Sell
9,658
-95
-1% -$18.7K 1.07% 33
2020
Q4
$1.77M Buy
9,753
+114
+1% +$19.4K 1.03% 39
2020
Q3
$1.45M Buy
9,639
+233
+2% +$39.2K 0.96% 39
2020
Q2
$1.53M Buy
9,406
+70
+0.7% +$12.5K 1.06% 36
2020
Q1
$1.67M Buy
9,336
+627
+7% +$125K 1.28% 25
2019
Q4
$1.74M Buy
8,709
+489
+6% +$100K 1.37% 33
2019
Q3
$1.74M Buy
8,220
+112
+1% +$23.4K 1.48% 24
2019
Q2
$1.58M Sell
8,108
-66
-0.8% -$12.2K 1.36% 36
2019
Q1
$1.34M Buy
8,174
+44
+0.5% +$7.78K 1.29% 39
2018
Q4
$1.53M Buy
+8,130
New +$1.5M 1.49% 27

Other funds holding CME

MACRO Consulting Group's CME Position: Q2 2021 in Review

MACRO Consulting Group increased its CME Group (CME) stake by 4.9% in Q2 2021, buying an estimated $100K and bringing the position to 10,133 shares worth $2.16M. The position accounts for 1.11% of the portfolio, ranked #34.

MACRO Consulting Group first reported a position in CME in Q4 2018 and has held it in 11 quarters since. 1,087 funds tracked by Wall St. Rank hold CME as of Q2 2021.

  • MACRO Consulting Group held 10,133 shares of CME Group worth $2.16M as of Q2 2021.
  • MACRO Consulting Group bought 475 CME Group shares in Q2 2021, an estimated $100K.
  • CME Group made up 1.11% of MACRO Consulting Group's portfolio in Q2 2021, its #34 holding.
  • MACRO Consulting Group first reported a position in CME Group in Q4 2018 and has held it in 11 quarters since.
  • 1,087 funds tracked by Wall St. Rank held CME Group as of Q2 2021.

Based on MACRO Consulting Group's 13F filing for Q2 2021, filed 16 Aug 2021.